TherapeuticsMD
Open
$2.08
Prev. Close
$2.08
High
$2.09
Low
$2.08
Market Snapshot
$24.42M
-42.9
-0.18
$1.76M
1
TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employees. The company went IPO on 2001-01-31. The company receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
emptyResult
TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employees. The company went IPO on 2001-01-31. The company receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Recently from Cashu
Please provide the content you'd like summarized, and I'll help you create a title!
Please provide the text or details you would like me to summarize.
TherapeuticsMD Stock Update: Key Developments and Future Outlook
Please provide the content you'd like me to summarize, and I'll be happy to help!
TherapeuticsMD: Key Developments and Insights on Recent Performance and Market Position
Please provide the content or details you would like me to summarize, and I will be happy to assist you.
TherapeuticsMD Secures FDA Approval for Innovative Hormonal Therapy for Women's Health
TherapeuticsMD Advances Hormonal Therapies with New FDA Approval TherapeuticsMD, a company dedicated to women’s health, achieves a significant milestone with the recent FDA approval of its latest horm…